THE VYRIX LAUNCH SALE — 50% OFF SITEWIDEGRAND OPENING — LIMITED TIMEVYRIX50
Retatrutide 20 MG

ISOLATES · 99%+

Retatrutide

20 MG

$449.99$599.9925% offIn Stock

High-strength lyophilized presentation of the triple-incretin research peptide, engineered for concurrent receptor binding within the incretin system. For in-vitro reconstitution.

USA
📦 Discreet Ship
Research Supply

Choose your batch

$449.99 $599.99 per vial · buy more, save more

Quantity
Sale price active

Add 2 more to unlock 5% off

$599.99
$449.99
save $150.00

Frequently bought together

Retatrutide
RetatrutideThis item
20 MG·Isolate
$599.99
$449.99
3 items selected
Bundle total
$1399.97
$1049.97

About this product

High-strength lyophilized presentation of the triple-incretin research peptide, engineered for concurrent receptor binding within the incretin system. For in-vitro reconstitution.

Purity & Testing

Purity ≥99%HPLC & MS

Research Use Only

This product is intended strictly for research and laboratory use. Not for human consumption, medical use, or diagnostic purposes. By purchasing, you agree to our Terms.

Retatrutide 20 MG

$449.99

1

Verified Test Results

Every batch, independently verified.

Batch VX-9776-604 of Retatrutide 20 MG was analyzed by an independent, ISO/IEC 17025 accredited laboratory. This is the released report for the current batch, exactly as the lab signed it.

N

Novak Testing Laboratory

Independent · ISO/IEC 17025 accredited

Certificate of Analysis

99.79%

Purity by HPLC

Lot

VX-9776-604

Tested

September 27, 2026

Labeled

20 mg

Measured

20.42 mg

ISO 17025 Accredited8× Tested

Full QC Panel

6 passed · 2 reported

Appearance

Visual

GoodPass

Identity

HPLC / MS

ConfirmedPass

Purity

HPLC

99.79%Pass

Net Peptide Content

HPLC

20.42 mgReported

Endotoxins

0.0469 EU/mgReported

Sterility

PCR

No GrowthPass

Heavy Metals

< 5 ppbPass

Fentanyl Screen

None DetectedPass

Cart (0)

Your cart is empty

Continue Shopping →

Have a promo code?